Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

Formation of Polyploid Giant Cancer Cells Involves in the Prognostic Value of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

We previously reported that polyploid giant cancer cells (PGCCs) exhibit cancer stem cell properties and can generate daughter cells with the epithelial-mesenchymal transition phenotype. This study investigated the role of PGCC formation in the prognostic value of neoadjuvant chemoradiation therapy...

Full description

Bibliographic Details
Main Authors:	Fei Fei, Mingqing Zhang, Bo Li, Lizhong Zhao, Hui Wang, Lina Liu, Yuwei Li, Po Ding, Yanjun Gu, Xipeng Zhang, Tao Jiang, Siwei Zhu, Shiwu Zhang
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2019/2316436

Similar Items

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2017-03-01)

The influence of neoadjuvant chemoradiation for lower rectal cancer on urinary function
by: Yugo Hirata, et al.
Published: (2019-07-01)

The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
by: Jie Sun, et al.
Published: (2019-05-01)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
by: Iacopino Bruno, et al.
Published: (2009-04-01)

Asymmetric Cell Division in Polyploid Giant Cancer Cells and Low Eukaryotic Cells
by: Dan Zhang, et al.
Published: (2014-01-01)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2021-07-01)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
by: Fabiana Bettoni, et al.
Published: (2019-09-01)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
by: Oliver J. Ott, et al.
Published: (2021-03-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

How accurate is MRI to predict response to neoadjuvant chemoradiation in locally advanced rectal cancer?
by: Afsaneh Alikhasi, et al.
Published: (2016-01-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)

Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer
by: Ju-Seog Lee, et al.
Published: (2021-03-01)

Neoadjuvant chemoradiation for locally advanced rectal cancer: a systematic review of the literature with network meta-analysis
by: Chen M, et al.
Published: (2019-01-01)

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
by: Shaan Dudani, et al.
Published: (2019-07-01)

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
by: Shaoyu Zhu, et al.
Published: (2019-11-01)

The expression of GLUT-1 and VEGF-A mRNA in the rectal cancer patients with neoadjuvant chemoradiation
by: Sri Nuryani Wahyuningrum, et al.
Published: (2020-12-01)

Early recurrence after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: Characteristics and risk factors
by: Han-Gil Kim, et al.
Published: (2021-01-01)

Sphincter saving and abdomino-perineal resections following neoadjuvant chemoradiation in locally advanced low rectal cancer
by: W. Gawad, et al.
Published: (2015-03-01)

Neoadjuvant chemoradiation with capcitabine and celecoxib in stage II and III rectal adenocarcinoma
by: Aghili M, et al.
Published: (2010-10-01)

Effect of Carbogen to Chemoradiation in Volume of Rectal Cancer
by: Christina Hari Nawangsih, et al.
Published: (2020-06-01)

Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial
by: C.S. Wong, et al.
Published: (2021-09-01)

Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation
by: Valerio Nardone, et al.
Published: (2019-01-01)

Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients
by: Shing Fung Lee, et al.
Published: (2018-09-01)

Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?
by: Kittinut Timudom, et al.
Published: (2016-01-01)

A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
by: Zhengfa Xue, et al.
Published: (2021-09-01)

Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response
by: Fan Q, et al.
Published: (2021-03-01)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
by: Habermehl Daniel, et al.
Published: (2012-03-01)

Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells
by: Kai Liu, et al.
Published: (2020-05-01)

A predictive genetic signature for response to fluoropyrimidine-based neoadjuvant chemoradiation in clinical Stage II and III rectal cancer
by: Jason eChan, et al.
Published: (2013-11-01)

Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients
by: Gabriella Macchia, et al.
Published: (2017-06-01)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
by: Raquel Conde-Muíño, et al.
Published: (2015-01-01)

Number of Polyploid Giant Cancer Cells and Expression of EZH2 Are Associated with VM Formation and Tumor Grade in Human Ovarian Tumor
by: Li Zhang, et al.
Published: (2014-01-01)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
by: Yaqi Wang, et al.
Published: (2019-04-01)

Tumor Budding, Micropapillary Pattern, and Polyploidy Giant Cancer Cells in Colorectal Cancer: Current Status and Future Prospects
by: Shiwu Zhang, et al.
Published: (2016-01-01)

Surgical treatment for locally advanced lower third rectal cancer after neoadjuvent chemoradiation with capecitabine: prospective phase II trial
by: Elsayed Mohamed, et al.
Published: (2009-06-01)

Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer
by: Hendrik Dapper, et al.
Published: (2018-12-01)

iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development.
by: Shiwu Zhang, et al.
Published: (2013-01-01)

Post chemoradiation re-staging of rectal cancer using MRI
by: Patel, Uday
Published: (2012)

Rectal cancer and chemoradiation in Iraq: systematic review and meta-analysis
by: Ahmed Salih Alshewered, et al.
Published: (2019-10-01)

PHYSIOLOGICALLY-INSPIRED RADIOMICS OF THE RECTAL ENVIRONMENT FOR PREDICTING AND EVALUATING RESPONSE TO CHEMORADIATION IN RECTAL CANCERS
by: Antunes, Jacob T., Antunes
Published: (2020)